Researchers identify potent new anti-obesity, anti-diabetes target
A team from The Scripps Research Institute (La Jolla, CA, USA) has identified a novel anti-obesity, anti-diabetes drug target.
Please sign in or register for FREE
Sign in to MedChemNet
Register to MedChemNet – the medicinal chemistry network
MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.